talectrectinib

Some perspective on TRUST-II with talectrectinib

IASLC shared on X:

“ In this episode, Narjust Florez and Stephen V Liu, recap WCLC24.

Jacob Sands discusses TROPION-Lung01 with datopotamab, deruxtecan and DeLLphi-301 with tarlatamab.

Hidehito Horinouchi reports results from the LUMINOSITY study, and Noemi Reguart gives some perspective on TRUST-II with talectrectinib.

Listen Now.”

Source: IASLC/X

cancer datopotamab DeLLphi-301 Deruxtecan Hidehito Horinouchi IASLC Jacob Sands LUMINOSITY study Narjust Florez Noemi Reguar OncoDaily Oncology Stephen V Liu talectrectinib Tarlatamab TROPION-Lung01 WCLC24